Altimmune Appoints Two Directors; Three to Retire After 2027 Annual Meeting
Altimmune appointed Peter Greenleaf and Alex Howarth to its board. John Gill, Mitchell Sayare and Klaus Schafer will retire after the 2027 annual meeting.
Altimmune appointed Peter Greenleaf and Alex Howarth to its board. John Gill, Mitchell Sayare and Klaus Schafer will retire after the 2027 annual meeting.